Exclusive: Vertex CSO David Altshuler talks non-opioid pain pills, AI and the myth of breakthroughs
Shortly after jumping from academia to industry in 2015, David Altshuler helped answer an existential question for Vertex Pharmaceuticals. The Boston biotech was riding high